Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Mahaffey

Showing results (381-390 of 635) with videos related to

Pageof 64
Sort By:
Circulation|July 18, 2013
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) RegistryBenjamin A Steinberg, Sunghee Kim, Jonathan P Piccini, et al.
American Heart Journal|August 10, 2016
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trialAxel Åkerblom, Robert M Clare, Yuliya Lokhnygina, et al.
Journal of the American Society of Nephrology : JASN|October 1, 2020
Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A <i>Post</i><i>Hoc</i> Analysis from the CREDENCE TrialMegumi Oshima, Brendon L Neuen, JingWei Li, et al.
Journal of the American Heart Association|May 31, 2021
Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLIDMarc D Samsky, Anne Hellkamp, William R Hiatt, et al.
Vascular Medicine (London, England)|June 4, 2021
Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y<sub>12</sub> inhibitors: Insights from the EUCLID trialJudith Hsia, Sarah T Kavanagh, Charles W Hopley, et al.
The American Journal of Cardiology|June 25, 2017
Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial)Jeffrey B Washam, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Circulation. Cardiovascular Interventions|February 24, 2022
Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPIONBenjamin E Peterson, Robert A Harrington, Gregg W Stone, et al.
Journal of the American College of Cardiology|June 27, 2015
Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation CohortLarry A Allen, Gregg C Fonarow, DaJuanicia N Simon, et al.
American Heart Journal|September 7, 2016
Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trialRohan Shah, Anne Hellkamp, Yuliya Lokhnygina, et al.
American Heart Journal|June 19, 2018
Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarctionJennifer A Rymer, Michael W Tempelhof, Robert M Clare, et al.
Pageof 64

Showing results (381-390 of 635) with videos related to

Sort By:
Pageof 64
Circulation|July 18, 2013
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) RegistryBenjamin A Steinberg, Sunghee Kim, Jonathan P Piccini, et al.
American Heart Journal|August 10, 2016
Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trialAxel Åkerblom, Robert M Clare, Yuliya Lokhnygina, et al.
Journal of the American Society of Nephrology : JASN|October 1, 2020
Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A <i>Post</i><i>Hoc</i> Analysis from the CREDENCE TrialMegumi Oshima, Brendon L Neuen, JingWei Li, et al.
Journal of the American Heart Association|May 31, 2021
Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLIDMarc D Samsky, Anne Hellkamp, William R Hiatt, et al.
Vascular Medicine (London, England)|June 4, 2021
Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y<sub>12</sub> inhibitors: Insights from the EUCLID trialJudith Hsia, Sarah T Kavanagh, Charles W Hopley, et al.
The American Journal of Cardiology|June 25, 2017
Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial)Jeffrey B Washam, Anne S Hellkamp, Yuliya Lokhnygina, et al.
Circulation. Cardiovascular Interventions|February 24, 2022
Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPIONBenjamin E Peterson, Robert A Harrington, Gregg W Stone, et al.
Journal of the American College of Cardiology|June 27, 2015
Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation CohortLarry A Allen, Gregg C Fonarow, DaJuanicia N Simon, et al.
American Heart Journal|September 7, 2016
Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trialRohan Shah, Anne Hellkamp, Yuliya Lokhnygina, et al.
American Heart Journal|June 19, 2018
Discharge timing and outcomes after uncomplicated non-ST-segment elevation acute myocardial infarctionJennifer A Rymer, Michael W Tempelhof, Robert M Clare, et al.
Pageof 64